JP2022505194A5 - - Google Patents

Info

Publication number
JP2022505194A5
JP2022505194A5 JP2021521143A JP2021521143A JP2022505194A5 JP 2022505194 A5 JP2022505194 A5 JP 2022505194A5 JP 2021521143 A JP2021521143 A JP 2021521143A JP 2021521143 A JP2021521143 A JP 2021521143A JP 2022505194 A5 JP2022505194 A5 JP 2022505194A5
Authority
JP
Japan
Prior art keywords
cells
trm
expressing
hypoxia
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021521143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505194A (ja
JP7698577B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057016 external-priority patent/WO2020081987A1/en
Publication of JP2022505194A publication Critical patent/JP2022505194A/ja
Publication of JP2022505194A5 publication Critical patent/JP2022505194A5/ja
Priority to JP2025018950A priority Critical patent/JP2025084776A/ja
Application granted granted Critical
Publication of JP7698577B2 publication Critical patent/JP7698577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521143A 2018-10-18 2019-10-18 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 Active JP7698577B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025018950A JP2025084776A (ja) 2018-10-18 2025-02-07 組織常在メモリー様ｔ細胞を生成するための方法及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862747523P 2018-10-18 2018-10-18
US62/747,523 2018-10-18
US201962846270P 2019-05-10 2019-05-10
US62/846,270 2019-05-10
PCT/US2019/057016 WO2020081987A1 (en) 2018-10-18 2019-10-18 Methods for production of tissue resident memory-like t cells and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025018950A Division JP2025084776A (ja) 2018-10-18 2025-02-07 組織常在メモリー様ｔ細胞を生成するための方法及びその使用

Publications (3)

Publication Number Publication Date
JP2022505194A JP2022505194A (ja) 2022-01-14
JP2022505194A5 true JP2022505194A5 (enExample) 2022-10-21
JP7698577B2 JP7698577B2 (ja) 2025-06-25

Family

ID=70284129

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021521143A Active JP7698577B2 (ja) 2018-10-18 2019-10-18 組織常在メモリー様ｔ細胞を生成するための方法及びその使用
JP2025018950A Withdrawn JP2025084776A (ja) 2018-10-18 2025-02-07 組織常在メモリー様ｔ細胞を生成するための方法及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025018950A Withdrawn JP2025084776A (ja) 2018-10-18 2025-02-07 組織常在メモリー様ｔ細胞を生成するための方法及びその使用

Country Status (7)

Country Link
US (2) US12319740B2 (enExample)
EP (1) EP3866814A4 (enExample)
JP (2) JP7698577B2 (enExample)
KR (1) KR20210078518A (enExample)
CN (1) CN113056276A (enExample)
CA (1) CA3115487A1 (enExample)
WO (1) WO2020081987A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12365871B2 (en) 2020-04-28 2025-07-22 Lyell Immunopharma, Inc. Methods for culturing cells
GB202007321D0 (en) * 2020-05-18 2020-07-01 Inst De Medicina Molecular Joaeo Lobo Antunes T cells
CN111944749A (zh) * 2020-08-14 2020-11-17 福建医科大学附属协和医院 一种用于治疗心肌梗死的人脂肪间充质干细胞外泌体的制备方法
CN112516141A (zh) * 2020-12-07 2021-03-19 浙江大学 Cd47表达抑制剂及其与免疫治疗药物联合使用
WO2022234856A1 (ja) * 2021-05-07 2022-11-10 康人 徳元 メモリーｔ細胞の製造方法
US20250281539A1 (en) * 2022-05-10 2025-09-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. Methods of culturing tumor infiltrating lymphocytes
CN115975921B (zh) * 2022-12-09 2025-12-19 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种体外诱导组织驻留性记忆cd8+t细胞的方法
CN121368631A (zh) * 2023-06-07 2026-01-20 新加坡科技研究局 基于小分子的修饰t细胞的方法
AU2024354387A1 (en) * 2023-10-02 2026-02-05 Immunitybio, Inc. Methods of generating, stimulating, or increasing proliferation of different subsets of cd8+ t cells
WO2025096644A1 (en) * 2023-10-31 2025-05-08 Immunitybio, Inc. Multi-chain chimeric polypeptides and use thereof in the treatment of advanced solid tumors
WO2025129119A1 (en) * 2023-12-15 2025-06-19 La Jolla Institute For Immunology Gpr25 agonization for cancer therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962318A (en) * 1996-11-15 1999-10-05 St. Jude Children's Research Hospital Cytotoxic T lymphocyte-mediated immunotherapy
US20080131415A1 (en) * 2006-11-30 2008-06-05 Riddell Stanley R Adoptive transfer of cd8 + t cell clones derived from central memory cells
WO2014039044A1 (en) 2012-09-06 2014-03-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of producing t memory stem cell populations
CN106146395B (zh) * 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3-羟基吡啶化合物、其制备方法及其制药用途
EP3324983A4 (en) * 2015-07-20 2019-04-10 Mayo Foundation for Medical Education and Research METHOD AND MATERIALS FOR PRODUCING T-CELLS
WO2017079113A1 (en) * 2015-11-02 2017-05-11 The United States Of America, As Represented By The Secretary, Department Of Healh And Human Services Methods of producing t cell populations using prolyl hydroxylase domain-containing protein inhibitors
WO2018106972A1 (en) * 2016-12-07 2018-06-14 La Jolla Institute For Allergy And Immunology Compositions for cancer treatment and methods and uses for cancer treatment and prognosis
US20240197782A1 (en) * 2021-04-20 2024-06-20 Board Of Regents, The University Of Texas System Methods and compositions for genetic modification and therapeutic use of immune cells

Similar Documents

Publication Publication Date Title
Selck et al. Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation
US20250002850A1 (en) Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptors
Goswami et al. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders–Advances and challenges
Symowski et al. Th2 cell‐derived IL‐4/IL‐13 promote ILC2 accumulation in the lung by ILC2‐intrinsic STAT6 signaling in mice
Clemente-Casares et al. Expanding antigen-specific regulatory networks to treat autoimmunity
Boardman et al. Flagellin-specific human CAR Tregs for immune regulation in IBD
Safinia et al. Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation
Yu et al. Harnessing the power of regulatory T‐cells to control autoimmune diabetes: overview and perspective
Kasahara et al. Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model
JP7254128B2 (ja) ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用
Lerret et al. Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells
Sanders et al. Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
CN104245923B (zh) 同种异型抗原‑反应性调节t细胞的增殖
Pinchuk et al. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells
JP2019536461A5 (enExample)
US20220380727A1 (en) Generation of engineered regulatory t cells
JP2019518460A (ja) 操作されたＴｒｅｇ細胞
JP2022505194A (ja) 組織常在メモリー様ｔ細胞を生成するための方法及びその使用
Wu et al. A method for expansion and retroviral transduction of mouse regulatory T cells
Baron et al. Clinical manufacturing of regulatory T cell products for adoptive cell therapy and strategies to improve therapeutic efficacy
Chien et al. Characterization of c-Maf+ Foxp3− regulatory T cells induced by repeated stimulation of antigen-presenting B cells
Wehrens et al. Treating arthritis by immunomodulation: is there a role for regulatory T cells?
Engelhardt et al. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells
Broom et al. Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes
WO2018117090A1 (ja) 制御性ｔ細胞の誘導方法